Skip to main content

We make finding a doctor in the UAE free, transparent, and easy.

Does allogeneic stem cell transplant treat chronic myeloid leukaemia?

How the structures involved in Chronic Myeloid Leukaemia differ from normal
Illustration: How the structures involved in Chronic Myeloid Leukaemia differ from normal

Short answer

Yes, an allogeneic stem cell transplant can treat chronic myeloid leukaemia in carefully selected people.

This answers one question. It is not a diagnosis and does not replace an assessment by a licensed doctor.

At a glance

Treatment type
Donor blood-forming stem cell transplant
Decision factors
CML phase, treatment response, health and donor match
Care team
Specialist haematology and transplant team

Direct answer

It replaces the patient's blood-forming cells with healthy stem cells from a donor. The donor cells rebuild blood production, and donor immune cells may also recognise and attack remaining leukaemia cells. Because transplantation can cause serious complications, it is generally considered only after an individual assessment.

What transplant means for CML

For many people with CML, medicines that target the abnormal leukaemia signal are used before a transplant is considered. A transplant may enter the discussion when the disease does not respond adequately, stops responding, progresses, or when suitable medicines cannot be tolerated. The decision depends on the phase of CML, previous treatment response, general health, organ function and whether a well-matched donor is available.

Preparation involves treatment to make room in the bone marrow and suppress the immune system before donor cells are infused. Recovery includes close monitoring while the new cells settle and start producing blood cells. Infection, graft-versus-host disease and effects on organs are among the issues the transplant team plans to prevent, detect and manage.

Preparing for a transplant decision

Keep a current list of CML medicines, doses, previous responses, side effects and other health conditions. The haematology team may arrange blood tests, bone marrow assessment, tissue matching, heart and lung checks, infection screening and a review of medicines. These results help compare the likely benefit of transplantation with its risks for you.

Plan for practical support as well as treatment. Ask who will help with travel, meals and medicines during recovery, and check which vaccinations or infection precautions the transplant unit recommends. Do not stop a CML medicine or change its dose while waiting for a transplant opinion unless your treating team directs you to do so.

When to seek prompt care

During transplant preparation or recovery, contact the transplant team urgently for fever, chills, new breathlessness, chest pain, confusion, uncontrolled vomiting or diarrhoea, unusual bleeding, a rapidly spreading rash, or inability to drink or keep medicines down. Follow the unit's specific temperature threshold and contact instructions, including outside clinic hours.

Call emergency services for severe breathing difficulty, collapse, a seizure or sudden loss of consciousness. If you are unsure whether a new symptom can wait, use the transplant team's urgent contact number because immune suppression can make infections worsen quickly.

Questions for your doctor

Ask why transplantation is being considered now, what your latest CML results show, whether further medicine options are reasonable, how donor matching will work, and what recovery support you will need. Also ask how fertility, vaccinations, work and follow-up may be affected.

Questions people ask

Is transplant the first treatment for CML?

Often, targeted medicines are used before transplantation is considered. The choice changes when CML response, progression, medicine tolerance or an individual's health makes a transplant assessment appropriate.

Why does donor matching matter?

Tissue matching helps the team choose a donor whose cells are more compatible with the recipient. Compatibility is one part of planning for engraftment and reducing immune complications.

Will I still need follow-up after the transplant?

Yes. Follow-up checks blood-cell recovery, CML markers, infections, medicine effects and signs that donor immune cells are affecting healthy tissues.

Related

Related reading

Keep reading

More on this

Cancer care in the UAE

Hospitals & Medical Centers in Abu Dhabi

Most UAE cancer care is delivered inside hospital services rather than by standalone oncology clinics, so these are licensed hospitals & medical centers listed in Abu Dhabi. Confirm the specific cancer service exists before you travel, and know that asking for a second opinion is routine.

City
  • Ahalia Hospital Musaffah Building - Musaffah - Musaffah Industrial - Abu Dhabi - United Arab Emirates

    Accepts: Daman, Thiqa, AXA, Cigna +26 more

  • Al Ruwais Industrial City - Abu Dhabi - United Arab Emirates

    Accepts: Daman, Thiqa, AXA, Cigna +30 more

  • Abu Dhabi, Abu Dhabi

    Accepts: Daman, Thiqa, AXA, Cigna +30 more

Second opinions are routine in cancer care and asking for one does not affect your treatment. How to arrange a second opinion in the UAE.

Ordered by verification status and how complete each clinic's public record is, then alphabetically. This is a directory listing, not a ranking — Zavis does not rate or recommend providers.

A factual listing drawn from the DHA, DOH and MOHAP licence registers. It is not a referral, an endorsement, or advice that any of these providers is right for you.

Medical disclaimer. This page is general health information, not medical advice, and it cannot diagnose you. Always consult a licensed healthcare provider about your own symptoms and treatment. In an emergency in the UAE, call 998 for an ambulance.